Myocardial protection in congenital heart surgery

Christian Schlensak1

  • 1Department of Cardiovascular Surgery, University Hospital Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany.

Insights

Pediatric cardiac surgery uses cardioplegic solutions and hypothermia to protect the heart during surgery. Current protection strategies are surgeon-dependent, lacking evidence-based guidelines for optimal myocardial protection.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiovascular Anesthesiology
  • Cardiothoracic Medicine

Background:

  • Modern pediatric cardiac surgery focuses on primary repair of congenital heart defects, often in neonates and infants.
  • Intracardiac repairs necessitate aortic cross-clamping, leading to cardiac ischemia.
  • Myocardial protection strategies, including cardioplegia and hypothermia, are crucial for limiting ischemia-reperfusion injury.

Purpose of the Study:

  • To review current myocardial protection strategies in pediatric cardiac surgery.
  • To highlight the variability and experience-based nature of these techniques.
  • To identify the lack of evidence-based guidelines for optimal myocardial protection.

Main Methods:

  • Review of current cardioplegic solutions and administration strategies (antegrade/retrograde, intermittent/single shot).
  • Discussion of the adjunctive role of hypothermia in extending ischemia tolerance.
  • Analysis of the surgeon-dependent nature of myocardial protection choices.

Main Results:

  • Multiple cardioplegic solutions and delivery methods are employed in pediatric cardiac surgery.
  • Hypothermia is commonly used in conjunction with cardioplegia.
  • No definitive evidence supports one technique over another, leading to practice variability.

Conclusions:

  • Myocardial protection strategies in pediatric cardiac surgery are currently based on surgeon preference and experience.
  • There is a need for evidence-based guidelines to standardize and optimize myocardial protection.
  • Further research is required to establish the most effective cardioplegic solutions and techniques.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460